KRT19 and adenocarcinoma: Oncogene-transformed derivatives of K5+/K19+ cells predominantly give luminal adenocarcinoma phenotype, whereas tumors arising from transformed K5+/K19− cell type produced more metaplastic carcinomas (Figure 3).